Neola Medical recently announced that the market preparations before the launch of the lung monitoring device Neola™ were initiated. The device is developed for continuous monitoring of the lungs of preterm born infants. One of the important activities this year in the market preparations was the attendance at the yearly J.P. Morgan Healthcare Conference, one of the worlds largest healthcare conferences. BioStock invited CEO Hanna Sjöström to get to know more about her impressions from the conference and the company’s business development plan. See the interview below (in Swedish).

Read more in an earlier interview about the conference